Relmada Therapeutics
RLMD
#7312
Rank
โ‚น52.72 B
Marketcap
โ‚น502.16
Share price
4.00%
Change (1 day)
706.95%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: โ‚น52.72 Billion

As of July 2026 Relmada Therapeutics has a market cap of โ‚น52.72 Billion. This makes Relmada Therapeutics the world's 7312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น52.72 B77.57%
2025โ‚น29.68 B2894.71%
2024โ‚น0.99 B-90.44%
2023โ‚น10.37 B19.34%
2022โ‚น8.69 B-81.31%
2021โ‚น46.51 B21.43%
2020โ‚น38.30 B-4.72%
2019โ‚น40.20 B1579.93%
2018โ‚น2.39 B298.43%
2017โ‚น0.60 B-32.61%
2016โ‚น0.89 B-55.28%
2015โ‚น1.99 B-81.1%
2014โ‚น10.54 B

End of Day market cap according to different sources

On Jul 23rd, 2026 the market cap of Relmada Therapeutics was reported to be:

โ‚น52.67 Billion
by Nasdaq info icon info icon
โ‚น52.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
โ‚น1.074 T 1,937.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
โ‚น155.96 B 195.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel